Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts.

Subsets of murine natural killer (NK) cells exist that express the Ly-49 family of molecules that recognize different major histocompatibility complex (MHC) determinants. Bone marrow transplantation studies were performed to examine the in vivo functions of 2 of these subsets. Subsets of Ly-49A and Ly-49G2 NK share specificity for the same MHC class 1 ligand, D(d), binding of which results in an inhibitory signal to the NK cell but allows them to lyse H2(b) targets in vitro. We therefore examined the ability of these subsets to reject H2(b) bone marrow cell allografts in lethally irradiated mice. Surprisingly, depletion of Ly-49A(+) NK cells in BALB/c or B10.D2 mice (both H2(d)) had no effect on the rejection of H2(b) BMC. However, Ly-49A depletion did partially abrogate the ability of B10.BR (H2(k)) mice to reject H2(b) allografts. Although depletion of either Ly-49A(+) or Ly-49G2(+) NK cells alone had no effect on the ability of B10.D2 mice to reject H2(b) BMC, depletion of both subsets dramatically and synergistically abrogated rejection. Studies with various B10 congenic mice and their F(1) hybrids indicate that this synergy between Ly49A and Ly4G2 depletion occurs in every instance. Thus, Ly-49A(+) NK cells appear to play a role in the rejection H2(b) bone marrow allografts, but, in most strains of mice studied, Ly-49G2(+) NK cells must also be eliminated. The putative roles of these NK cell subsets in clinical transplantation remains to be elucidated. (Blood. 2000;95:3840-3844)

[1]  D. Busch,et al.  Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. , 1999, Immunity.

[2]  J. Ortaldo,et al.  Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. , 1999, Journal of immunology.

[3]  E. Alnemri,et al.  Natural Killer (NK) Cell–mediated Cytotoxicity: Differential Use of  TRAIL and Fas Ligand by Immature and Mature Primary Human NK Cells , 1998, The Journal of experimental medicine.

[4]  M. Bunce,et al.  Molecular Typing Shows a High Level of HLA Class I Incompatibility in Serologically Well Matched Donor/Patient Pairs: Implications for Unrelated Bone Marrow Donor Selection , 1998 .

[5]  D. Longo,et al.  Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. , 1998, Journal of immunology.

[6]  Eric O Long,et al.  Killer cell inhibitory receptors: diversity, specificity, and function , 1997, Immunological reviews.

[7]  D. Longo,et al.  Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice. , 1996, International immunology.

[8]  D. Cado,et al.  Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection , 1996, The Journal of experimental medicine.

[9]  C. Benoist,et al.  Independent Modes of Natural Killing Distinguished in Mice Lacking Lag3 , 1996, Science.

[10]  E. Podack,et al.  Perforin- and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice. , 1995, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  D. Longo,et al.  NK cell subsets in the regulation of murine hematopoiesis. I. 5E6+ NK cells promote hematopoietic growth in H-2d strain mice. , 1995, Journal of immunology.

[12]  D. Raulet,et al.  Natural killer cell receptors: The offs and ons of NK cell recognition , 1995, Cell.

[13]  S. Anderson,et al.  Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2) , 1995, The Journal of experimental medicine.

[14]  E. Wakeland,et al.  Cloning and characterization of 5E6(Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells , 1995, The Journal of experimental medicine.

[15]  K. Kärre,et al.  Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Margulies,et al.  Host MHC class I molecules modulate in vivo expression of a NK cell receptor. , 1994, Journal of immunology.

[17]  W. Yokoyama,et al.  Ly-49 multigene family expressed by IL-2-activated NK cells. , 1994, Journal of immunology.

[18]  W. Seaman,et al.  A natural killer cell receptor specific for a major histocompatibility complex class I molecule , 1994, The Journal of experimental medicine.

[19]  K. Kane,et al.  Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules , 1994, The Journal of experimental medicine.

[20]  Craig W. Reynolds,et al.  Natural killer cells and bone marrow transplantation. , 1993, Journal of the National Cancer Institute.

[21]  W. Yokoyama,et al.  MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells , 1992, Nature.

[22]  M. Bennett,et al.  Murine natural killer cells and marrow graft rejection. , 1992, Annual review of immunology.

[23]  I. Weissman,et al.  Mouse hematopoietic stem cells. , 1991, Blood.

[24]  D. Mager,et al.  Ly-49 multigene family. New members of a superfamily of type II membrane proteins with lectin-like domains. , 1991, Journal of immunology.

[25]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.

[26]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[27]  J. Ortaldo,et al.  LGL-1: a non-polymorphic antigen expressed on a major population of mouse natural killer cells. , 1988, Journal of immunology.

[28]  W. Murphy,et al.  Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized , 1987, The Journal of experimental medicine.

[29]  K. Kärre ROLE OF TARGET HISTOCOMPATIBILITY ANTIGENS IN REGULATION OF NATURAL KILLER ACTIVITY: A REEVALUATION AND A HYPOTHESIS1 , 1985 .

[30]  J. Ortaldo,et al.  Heterogeneity of natural killer cells. , 1984, Annual review of immunology.

[31]  M. Bennett,et al.  PECULIAR IMMUNOBIOLOGY OF BONE MARROW ALLOGRAFTS , 1971, Journal of Experimental Medicine.